CytoMed Financial Statements From 2010 to 2025

CytoMed Therapeutics Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 5.5 M 7.4 M 3.5 M Slightly volatile Short and Long Term Debt Total 322.2 K 339.2 K 862.1 K Slightly volatile Other Current Liabilities 331.9 K 382.3 K 266.7 K Slightly volatile Total Current Liabilities 422 K 444.2 K 720.9 K Slightly volatile Total Stockholder Equity 3.5 M 6.6 M 2.2 M Slightly volatile Net Tangible Assets 485.8 K 511.4 K 1.5 M Slightly volatile Property Plant And Equipment Net 2 M 2.4 M 1.8 M Slightly volatile Accounts Payable 21.2 K 28.3 K 13.7 K Slightly volatile Cash 2.6 M 3.6 M 1.2 M Slightly volatile Non Current Assets Total 2.3 M 3 M 1.9 M Slightly volatile Cash And Short Term Investments 2.7 M 3.6 M 1.3 M Slightly volatile Net Receivables 13.1 K 13.8 K 33.2 K Slightly volatile Good Will 212 260 261 Slightly volatile Common Stock Shares Outstanding 8.9 M 11.5 M 6.7 M Slightly volatile Short Term Investments 210.4 K 200.4 K 71.1 K Slightly volatile Liabilities And Stockholders Equity 5.5 M 7.4 M 3.5 M Slightly volatile Non Current Liabilities Total 308.1 K 305.6 K 425.1 K Slightly volatile Inventory 384.3 K 614.2 K 175 K Slightly volatile Other Current Assets 219.2 K 126.5 K 105.7 K Slightly volatile Total Liabilities 1.5 M 749.8 K 1.2 M Slightly volatile Total Current Assets 3.3 M 4.4 M 1.5 M Slightly volatile Short Term Debt 31.9 K 33.6 K 438.1 K Slightly volatile Intangible Assets 71.3 K 67.9 K 30.3 K Slightly volatile Common Stock 9.5 M 17.4 M 5.1 M Slightly volatile Property Plant Equipment 2.6 M 2.8 M 2.4 M Slightly volatile Current Deferred Revenue 114.6 K 109.2 K 31.9 K Slightly volatile Long Term Debt 384.1 K 394.3 K 543.2 K Slightly volatile Capital Lease Obligations 17 K 31.3 K 27.2 K Slightly volatile Net Invested Capital 7.7 M 9.4 M 4.8 M Slightly volatile Property Plant And Equipment Gross 4 M 5 M 3.1 M Slightly volatile Short and Long Term Debt 35.8 K 37.6 K 2 M Slightly volatile Capital Stock 14.6 M 23.8 M 7.3 M Slightly volatile
CytoMed Therapeutics Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 136.6 K 91.6 K 127.3 K Slightly volatile Other Operating Expenses 1.5 M 2.7 M 881.6 K Slightly volatile Research Development 1 M 1.4 M 602.3 K Slightly volatile Total Operating Expenses 1.4 M 1.9 M 815.3 K Slightly volatile Interest Expense 14.4 K 15.2 K 70.2 K Slightly volatile Selling General Administrative 1.3 M 1.2 M 312.7 K Slightly volatile Selling And Marketing Expenses 15.3 K 23.8 K 8.9 K Slightly volatile Total Revenue 49.4 K 52 K 77.5 K Slightly volatile Cost Of Revenue 24.8 K 22.7 K 10.8 K Slightly volatile Reconciled Depreciation 381 K 335.4 K 314.9 K Slightly volatile Minority Interest 5.4 K 5.2 K 838 Slightly volatile
CytoMed Therapeutics Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Begin Period Cash Flow 5 M 4.7 M 1.3 M Slightly volatile Depreciation 261.4 K 245.6 K 179.7 K Slightly volatile Capital Expenditures 534.1 K 1 M 706.5 K Slightly volatile End Period Cash Flow 2.2 M 3.4 M 1.1 M Slightly volatile Change To Netincome 1.5 M 1.4 M 419 K Slightly volatile Change To Liabilities 177.3 K 293.3 K 112.7 K Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 792 754 501 Very volatile PTB Ratio 5.68 5.9764 20.3518 Pretty Stable Days Sales Outstanding 77.22 86.87 94.7099 Slightly volatile Book Value Per Share 0.6 0.5738 0.3086 Slightly volatile Average Payables 23.4 K 23.5 K 23.5 K Slightly volatile Capex To Depreciation 2.71 4.1753 4.8113 Slightly volatile PB Ratio 5.68 5.9764 20.3518 Pretty Stable EV To Sales 349 691 491 Slightly volatile Inventory Turnover 0.0413 0.037 0.0307 Slightly volatile Days Of Inventory On Hand 9.4 K 9.9 K 21.4 K Pretty Stable Payables Turnover 1.39 0.8037 0.7829 Slightly volatile Sales General And Administrative To Revenue 25.07 23.8806 5.2483 Slightly volatile Average Inventory 250.4 K 337.6 K 271.9 K Slightly volatile Research And Ddevelopement To Revenue 28.85 27.4751 16.6387 Very volatile Capex To Revenue 20.7 19.7149 5.7012 Slightly volatile Cash Per Share 0.21 0.3154 0.1447 Slightly volatile Days Payables Outstanding 431 454 1.5 K Very volatile Income Quality 0.58 1.0768 0.7306 Very volatile Intangibles To Total Assets 0.0079 0.0092 0.0102 Slightly volatile Current Ratio 10.39 9.892 3.1998 Slightly volatile Tangible Book Value Per Share 0.6 0.5679 0.3045 Slightly volatile Receivables Turnover 3.02 3.4 3.7102 Slightly volatile Shareholders Equity Per Share 0.6 0.5689 0.3083 Slightly volatile Debt To Equity 0.0491 0.0517 1.1458 Pretty Stable Capex Per Share 0.0713 0.0888 0.1172 Slightly volatile Revenue Per Share 0.0043 0.0045 0.01 Slightly volatile Interest Debt Per Share 0.0292 0.0307 0.1348 Pretty Stable Debt To Assets 0.0437 0.046 0.2839 Very volatile Operating Cycle 9.5 K 10 K 21.4 K Pretty Stable Price Book Value Ratio 5.68 5.9764 20.3518 Pretty Stable Days Of Payables Outstanding 431 454 1.5 K Very volatile Ebt Per Ebit 1.25 0.7186 1.2461 Slightly volatile Company Equity Multiplier 1.07 1.1229 2.3603 Pretty Stable Long Term Debt To Capitalization 0.04 0.0421 0.229 Pretty Stable Total Debt To Capitalization 0.0467 0.0491 0.3135 Very volatile Debt Equity Ratio 0.0491 0.0517 1.1458 Pretty Stable Quick Ratio 8.93 8.5092 2.8598 Slightly volatile Net Income Per E B T 1.12 0.998 1.0399 Pretty Stable Cash Ratio 8.6 8.1935 2.5525 Slightly volatile Cash Conversion Cycle 9 K 9.5 K 19.8 K Pretty Stable Days Of Inventory Outstanding 9.4 K 9.9 K 21.4 K Pretty Stable Days Of Sales Outstanding 77.22 86.87 94.7099 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 1.72 1.5167 2.2951 Slightly volatile Price To Book Ratio 5.68 5.9764 20.3518 Pretty Stable Fixed Asset Turnover 0.0207 0.0218 0.0464 Slightly volatile Debt Ratio 0.0437 0.046 0.2839 Very volatile Price Sales Ratio 792 754 501 Very volatile Asset Turnover 0.0067 0.0071 0.0166 Very volatile Gross Profit Margin 0.84 1.0072 0.9743 Slightly volatile Price Fair Value 5.68 5.9764 20.3518 Pretty Stable
CytoMed Therapeutics Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 50.2 M 39.2 M 51.2 M Slightly volatile Enterprise Value 44.9 M 35.9 M 45 M Slightly volatile

CytoMed Fundamental Market Drivers

CytoMed Upcoming Events

About CytoMed Therapeutics Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether CytoMed Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CytoMed Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cytomed Therapeutics Limited Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cytomed Therapeutics Limited Stock:

How To Invest In CytoMed Details

Is CytoMed Stock a good investment? Details

What is CytoMed Therapeutics' Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details